Garg Pushkal Insider Trades

Insider Trading History

Track insider trading activity for Garg Pushkal. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $5.98M 20,443 shares
Last Trade
Mar 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$779k 2,404 shares
$323.97
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $6.82M 23,300 shares
Last Trade
Mar 04, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$746k 2,309 shares
$323.09
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.26M 24,826 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$568k 1,775 shares
$319.74
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.86M 26,848 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$563k 1,717 shares
$327.65
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.87M 26,898 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.96M 15,249 shares
$325.07
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $0 0 shares
Last Trade
Feb 27, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$635k 1,908 shares
$332.76
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.83M 26,756 shares
Last Trade
Feb 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$635k 1,908 shares
$332.76
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.79M 26,629 shares
Last Trade
Feb 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.53M 4,627 shares
$331.34
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.27M 24,848 shares
Last Trade
Feb 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$695k 2,242 shares
$310.08
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.93M 27,090 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 4,579 shares
$308.48
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.02M 23,982 shares
Last Trade
Jan 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$548k 1,510 shares
$362.87
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.03M 24,021 shares
Last Trade
Jan 11, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.51M 3,800 shares
$398.29
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $6.6M 22,561 shares
Last Trade
Oct 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.36M 3,022 shares
$451.48
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $7.63M 26,065 shares
Last Trade
Oct 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.33M 2,937 shares
$452.05
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $6.74M 23,033 shares
Last Trade
Aug 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$58k 129 shares
$449.33
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
EVP Chief R&d
Holding Value $6.75M 23,072 shares
Last Trade
Aug 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 2,851 shares
$448.91
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CMO & EVP Dev & Med Affairs
Holding Value $7.51M 25,666 shares
Last Trade
Mar 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.58M 5,445 shares
$290.70
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CMO & EVP Dev & Med Affairs
Holding Value $0 0 shares
Last Trade
Mar 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.58M 5,445 shares
$290.70
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CMO & EVP Dev & Med Affairs
Holding Value $5.92M 20,221 shares
Last Trade
Mar 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.63M 5,445 shares
$300.00
$292.58
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
CMO & EVP Dev & Med Affairs
Holding Value $5.92M 20,221 shares
Last Trade
Mar 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.23M 4,321 shares
$285.00
$292.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up